These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16990766)

  • 1. Quantification of marrow CD34+ cells: An important tool for distinguishing between hypoplastic myelodysplastic syndromes and aplastic anemia.
    Orazi A
    Leukemia; 2006 Nov; 20(11):2041; author reply 2041-2. PubMed ID: 16990766
    [No Abstract]   [Full Text] [Related]  

  • 2. [Differential diagnosis between aplastic anemia and hypoplastic myelodysplastic syndromes: from the viewpoint of pediatrics].
    Hama A; Ito M; Kojima S
    Rinsho Ketsueki; 2012 Oct; 53(10):1485-91. PubMed ID: 23037720
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes.
    Matsui WH; Brodsky RA; Smith BD; Borowitz MJ; Jones RJ
    Leukemia; 2006 Mar; 20(3):458-62. PubMed ID: 16437138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aplastic anaemia versus hypocellular myelodysplastic syndrome.
    Varma N; Varma S; Marwaha N; Garewal G
    Indian J Cancer; 1995 Sep; 32(3):110-5. PubMed ID: 8772810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD34 and p53 immunohistochemical stains differentiate hypocellular myelodysplastic syndrome (hMDS) from aplastic anemia and a CD34 immunohistochemical stain provides useful survival information for hMDS.
    Cha CH; Park CJ; Chi HS; Seo EJ; Jang S; Cho YU; Lee KH; Lee JH; Lee JH; Im HJ; Seo JJ
    Ann Lab Med; 2014 Nov; 34(6):426-32. PubMed ID: 25368817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A flow cytometric approach to compare stem cell apoptosis in aplastic anemia and hypoplastic myelodysplastic syndrome.
    Ibrahim M; Khodeary A; Aziz SP; Mahmoud MG; Abdel-Baset AA; Mohamed T; Sayed SA
    Hematol Oncol Stem Cell Ther; 2024 Jul-Sep 01; 17(3):184-189. PubMed ID: 39412754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotype of myeloid granulocytes: a pilot study for distinguishing myelodysplastic syndrome and aplastic anemia by flow cytometry.
    Huang M; Li J; Zhao G; Sui X; Zhao X; Xu H
    Int J Lab Hematol; 2010 Jun; 32(3):275-81. PubMed ID: 19968721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study of hypoplastic myelodysplastic syndrome].
    Sato Y; Mituhashi S; Otani K; Kamoshita M; Hasegawa Y; Ninomiya H; Nagasawa T; Abe T
    Rinsho Ketsueki; 1993 Nov; 34(11):1431-7. PubMed ID: 8254904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens.
    Orazi A; Albitar M; Heerema NA; Haskins S; Neiman RS
    Am J Clin Pathol; 1997 Mar; 107(3):268-74. PubMed ID: 9052376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Relevance of p53 Immunohistochemical Stain in the Differential Diagnosis Between Pediatric Aplastic Anemia and Refractory Cytopenia of Childhood.
    Park SH; Chi HS; Cho YU; Jang S; Park CJ; Im HJ; Seo JJ
    Ann Lab Med; 2016 Mar; 36(2):174-6. PubMed ID: 26709267
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thoughts on differential diagnosis between aplastic anemia and hypoplastic myelodysplastic syndrome].
    Shi J; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Oct; 34(10):910-2. PubMed ID: 24171972
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypoplastic myelodysplastic syndrome associated with der(1;7)(q10;p10) presenting as bone marrow failure.
    Cho SY; Oh SH; Suh JT; Lee HJ; Lee WI; Baek SK; Cho KS; Park TS
    Acta Haematol; 2011; 126(2):110-3. PubMed ID: 21646778
    [No Abstract]   [Full Text] [Related]  

  • 13. Myelodysplastic syndrome and aplastic anemia--diagnostic and conceptual uncertainties.
    Barrett J
    Leuk Res; 2000 Jul; 24(7):595-6. PubMed ID: 10867134
    [No Abstract]   [Full Text] [Related]  

  • 14. The differential diagnosis between aplastic anemia and hypocellular myelodysplasia in patients with pancytopenia.
    Lorand-Metze I; Meira DG; Lima CS; Vassallo J; Metze K
    Haematologica; 1999 Jun; 84(6):564-5. PubMed ID: 10366807
    [No Abstract]   [Full Text] [Related]  

  • 15. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoplastic myelodysplasia (MDS).
    Geary CG; Marsh JC; Gordon-Smith EC
    Br J Haematol; 1996 Sep; 94(3):582-3. PubMed ID: 8790165
    [No Abstract]   [Full Text] [Related]  

  • 17. [In vitro proliferation and differentiation of bone marrow stem cells of aplastic anemia patients].
    Chen G; Shao Z; Jia H
    Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):529-31. PubMed ID: 11721400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?
    Barrett J; Saunthararajah Y; Molldrem J
    Semin Hematol; 2000 Jan; 37(1):15-29. PubMed ID: 10676908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anaemia by bone marrow stem cell expression of the tumour necrosis factor receptor.
    Kasahara S; Hara T; Itoh H; Ando K; Tsurumi H; Sawada M; Yamada T; Ohnishi H; Moriwaki H
    Br J Haematol; 2002 Jul; 118(1):181-8. PubMed ID: 12100146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atypical clinical course of aplastic anemia in childhood from hemopoietic dysplasia].
    Ohara A; Tsuchida M; Tsukimoto I; Nakayama K; Hanawa Y
    Rinsho Ketsueki; 1987 Apr; 28(4):616-23. PubMed ID: 3626052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.